Boston Scientific said it likely won't meet its financial guidance due to a cyberattack that has disrupted operations, with shares down sharply in premarket trading. The medical-technology company disclosed the impact Tuesday, noting it continues to make progress in restoring its systems. The attack has forced the company to withdraw its previous outlook, creating uncertainty for investors.

Shares fell sharply in premarket trading following the announcement.